Which Dose of Acetaminophen is Safe in Cirrhotic Patients?

authors:

avatar Hassan Soleimanpour ORCID 1 , avatar Zahra Parsian ORCID 2 , avatar Kavous Shahsavari Nia ORCID 3 , avatar Farzad Rahmani 3 , avatar Seyed Moayed Alavian ORCID 4 , 5 , *

Emergency Medicine Research Team, Tabriz University of Medical Sciences, Tabriz, Iran
Aging Research Institute, Tabriz University of Medical Sciences, Tabriz, Iran
Road Traffic Injury Research Center, Tabriz University of Medical Sciences, Tabriz, Iran
Baqiyatallah Research Center for Gastroenterology and Liver Diseases, Baqiyatallah University of Medical Sciences, Tehran, Iran
Tehran Hepatitis Center, Tehran, Iran

how to cite: Soleimanpour H, Parsian Z , Shahsavari Nia K , Rahmani F , Alavian S M. Which Dose of Acetaminophen is Safe in Cirrhotic Patients?. Hepat Mon. 2019;19(5):e84767. https://doi.org/10.5812/hepatmon.84767.

References

  • 1.

    Imani F, Motavaf M, Safari S, Alavian SM. The therapeutic use of analgesics in patients with liver cirrhosis: A literature review and evidence-based recommendations. Hepat Mon. 2014;14(10). e23539. [PubMed ID: 25477978]. [PubMed Central ID: PMC4250965]. https://doi.org/10.5812/hepatmon.23539.

  • 2.

    Soleimanpour M, Imani F, Safari S, Sanaie S, Soleimanpour H, Ameli H, et al. The role of non-steroidal anti-inflammatory drugs (NSAIDS) in the treatment of patients with hepatic disease: A review article. Anesth Pain Med. 2016;6(4). e37822. [PubMed ID: 27843779]. [PubMed Central ID: PMC5100664]. https://doi.org/10.5812/aapm.37822.

  • 3.

    Andreasen PB, Hutters L. Paracetamol (acetaminophen) clearance in patients with cirrhosis of the liver. Acta Med Scand Suppl. 1979;624:99-105. [PubMed ID: 284720].

  • 4.

    Hayward KL, Powell EE, Irvine KM, Martin JH. Can paracetamol (acetaminophen) be administered to patients with liver impairment? Br J Clin Pharmacol. 2016;81(2):210-22. [PubMed ID: 26460177]. [PubMed Central ID: PMC4833155]. https://doi.org/10.1111/bcp.12802.

  • 5.

    Riley TR, Smith JP. Preventive care in chronic liver disease. J Gen Intern Med. 1999;14(11):699-704. [PubMed ID: 10571719]. [PubMed Central ID: PMC1496761]. https://doi.org/10.1046/j.1525-1497.1999.11188.x.

  • 6.

    Lewis JH, Stine JG. Review article: Prescribing medications in patients with cirrhosis - a practical guide. Aliment Pharmacol Ther. 2013;37(12):1132-56. [PubMed ID: 23638982]. https://doi.org/10.1111/apt.12324.

  • 7.

    Lucena MI, Andrade RJ, Tognoni G, Hidalgo R, Sanchez de la Cuesta F; Spanish Collaborative Study Group on Therapeutic Management of Liver Diseases. Drug use for non-hepatic associated conditions in patients with liver cirrhosis. Eur J Clin Pharmacol. 2003;59(1):71-6. [PubMed ID: 12684727]. https://doi.org/10.1007/s00228-003-0586-2.

  • 8.

    Hirschfield GM, Kumagi T, Heathcote EJ. Preventative hepatology: Minimising symptoms and optimising care. Liver Int. 2008;28(7):922-34. [PubMed ID: 18783540]. https://doi.org/10.1111/j.1478-3231.2008.01816.x.

  • 9.

    Benson GD. Acetaminophen in chronic liver disease. Clin Pharmacol Ther. 1983;33(1):95-101. [PubMed ID: 6848304]. https://doi.org/10.1038/clpt.1983.14.